Blood lancet misuse potential, labelling issues addressed by US FDA panel
This article was originally published in SRA
Executive Summary
While the US Food and Drug Administration has a full knowledge of the health risks associated with the use of blood lancet devices, there are concerns over possible misuse and about certain information relating to the severity of the risks. Those were the main conclusions of the FDA’s general and plastic surgery devices panel meeting of 26 June 2013.